Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 17 (12), 1643-1652, 2016-12
Elsevier BV